One ‘Aw Sh*t’ Wipes Out 1,000 ‘attaboys’

I must have heard or used variations of this month’s quote several hundred times during my military career. As a resident physician, my existence seemed to be ruled by this postulate, since months of smooth sailing at work could be wiped out in seconds by the smallest error. Good works seemed to fade in the collective memory of my superiors overnight, but mistakes appeared to stain my reputation in perpetuity. I guess whether it is resident relations with staff or international relations between countries, one’s reputation is only as formidable as the magnitude of one’s last mistake.

Polygenic Scores Show Limited Value in Cardiovascular Risk Prediction for Breast Cancer Survivors

Approximately 4 million women in the United States are living with breast cancer, a number that reflects advances in screening and treatment. As survivorship improves, attention has increasingly shifted toward long-term risks such as cardiovascular disease (CVD), a leading cause of mortality in this population and a growing concern within the VA, given the increasing number of women veterans.

Expert Panel Recommended Regular Review of Psychotropic Medications

Psychotropic medications are often prescribed for many complex, difficult-to-treat psychiatric disorders and include antidepressants, anti-anxiety agents, antipsychotics, mood stabilizers and stimulants. New guidance has suggested there’s a need for greater recognition of clinical psychopharmacology endpoints.

Cancer Vaccines in Lung Cancer: A New Strategy to Overcome Immunotherapy Resistance

Immune checkpoint inhibitor (ICI) resistance can be caused by tumor evasion mechanisms that prevent T cells from recognizing or killing cancer cells. Cancer vaccines are designed to address those challenges by stimulating the immune system to recognize tumor-specific antigens. Unlike preventive vaccines, these therapeutic approaches can “induce de novo or amplify pre-existing tumor-specific immune responses, thereby enhancing long-term immunological memory while maintaining a favorable safety profile,” according to a new study.

Acalabrutinib Gains Ground as Preferred BTK Inhibitor for CLL/SLL in Veterans Likely to Have Co-Morbidities

Veterans with chronic lymphocytic leukemia and small lymphocytic leukemia tend to be very different than typical clinical trial populations, presenting with diagnoses of hypertension, type 2 diabetes, chronic kidney disease, obstructive sleep apnea, and post-traumatic stress disorder, among other conditions. That is why VA’s oncology clinical pathways now prefer a first-line therapy that has demonstrated efficacy across high-risk genomic subgroups, has a lower rate of adverse effects and is compatible with the complex comorbidity profile common among older veterans.

More Genetic Testing, New Drug Combinations Hold Promise for Prostate Cancer With Germline Variants

Pathogenic germline variants might be found in a relatively small percentage of prostate cancer patients, but they can make the prognosis much, much worse. Now, the future is looking brighter, with the VA and other healthcare systems spearheading more testing. At the same time, drug combinations involving PARP inhibitors are showing some success in lengthening survival.

B-Cell Lymphomas in Veterans: Expanding the Role of Next-Generation BTK Inhibition

The PACT Act marked the largest single expansion of veterans’ benefits for toxic exposure in the history of the VA. Among its most consequential provisions for hematology-oncology care, the legislation established lymphomas of any type as presumptive service-connected conditions for veterans who served in qualifying locations during the Gulf War era or in the post-September 11, 2001, conflicts.

Veterans With ALS Report High Satisfaction With VA Care Compared to Outside Care

Veterans With ALS Report High Satisfaction With VA Care Compared to Outside Care

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurogenerative disease that has devastating symptoms. It is 1.5 times more common in military veterans than those who never served. A recent survey found that veterans with the disease gave high marks to VA’s highly comprehensive and coordinated system to manage their care.

Ultrasound Guided by MRI Effective Therapy for Parkinson’s Symptoms

Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy, a noninvasive, incision-free and radiation-free therapeutic technology that uses high-intensity ultrasound waves to destroy specific tissue, guided by real-time MRI for precision, is increasingly used for managing symptoms in patients with essential tremor (ET) and Parkinson’s disease (PD).